Nakova G, Ognianova V
Eksp Med Morfol. 1979;18(1):12-7.
The authors carried out studies of the original Bulgarian preparation Adepren on male rats Wistar with a weight of 170-200 gm. Single groups of animals were treated singly with venous doses respectively 2,5 and 10 mg/kg of body weight, but other three groups with oral administration of 10, 100 and 200 mg/kg of body weight. The content of the preparation was determined after decapitation of the rats at various intervals of time in plasma, brain, liver and kidneys. Excretion was examined in urine and feces for a period of four days and nights (in metabolic cages). There was a slow resorption of Adepren in the gastro-intestinal tract. The preparation underwent biotransformation in the organism of the rats after oral usage and the basic metabolite was 4-aminocholine, excreted in urine. Adepren and its metabolites were excreted in rats mainly through urine.
作者对体重为170 - 200克的雄性Wistar大鼠进行了关于保加利亚原装制剂阿地普明(Adepren)的研究。单组动物分别静脉注射2、5和10毫克/千克体重的剂量进行单独治疗,而其他三组则口服10、100和200毫克/千克体重的剂量。在大鼠断头后的不同时间间隔,测定血浆、脑、肝和肾中该制剂的含量。在代谢笼中对尿液和粪便进行了为期四天四夜的排泄检查。阿地普明在胃肠道的吸收缓慢。口服后该制剂在大鼠体内进行生物转化,主要代谢产物是4 - 氨基胆碱,经尿液排泄。阿地普明及其代谢产物在大鼠体内主要通过尿液排泄。